HaploX is a biotechnology company that aims to improve cancer patient management by integrating liquid biopsy technology, gene sequencing, artificial intelligence, big data, and other technologies. Its technologies include tools for extracting and amplifying ultra-low concentrations of DNA from liquid samples, performing tagged sequencing, and managing and analyzing the resulting data.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.